ACN vs FCN: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of October 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. ACN and FCN share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined ACN and FCN exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Accenture is a global professional services company that helps businesses, governments, and other organizations across more than 120 countries build digital infrastructure, optimize operations, and accelerate growth. The company operates across five major service areas: Strategy and Consulting, Technology Services, Operations, Industry X (engineering and manufacturing digitization), and Song (marketing and customer experience). It earns revenue through a mix of consulting engagements, managed services contracts, and increasingly fixed-price, outcome-based arrangements, with managed services growing faster at roughly 10% year over year as of Q2 FY2026. The company serves clients in virtually every major industry vertical, from financial services and health to communications and government, and generates the majority of its revenue outside North America.

Full ACN guide

FTI Consulting is a global expert firm that advises corporations, law firms, governments, and financial institutions through five segments: Corporate Finance and Restructuring (its largest, roughly 41% of revenue), Forensic and Litigation Consulting (~20%), Economic Consulting (~19%), Technology (~10%), and Strategic Communications (~10%). Its work spans turnaround and restructuring, transactions, disputes and investigations, antitrust and regulatory economics, e-discovery, and corporate reputation. The firm employs roughly 8,100 people, of whom about 6,400 are billable professionals, and generates around 63% of revenue from US-based professionals.

Full FCN guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• ACN drivers: Enterprise AI implementation at scale; Shift to recurring, outcome-based revenue.
• FCN drivers: Restructuring and Corporate Finance strength; Record Strategic Communications demand.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The most structural bear-case concern is AI cannibalization: if generative AI and agentic AI tools automate the coding, testing, documentation, and process management that make up a significant portion of Accenture's billable work, clients may require fewer hours per engagement, compressing revenue without a commensurate reduction in costs. For FCN, the Economic Consulting segment has been a clear drag, with revenue declining and swinging to a segment EBITDA loss on softer antitrust and economic-analysis demand plus elevated compensation; the October 2026 leadership change at Compass Lexecon is an attempt to reset that unit.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick ACN if you believe its drivers more; FCN if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the ACN and FCN guides.

ACN. At ~$227.69 on October 16, 2026, Accenture trades at about 16.8x trailing earnings and ~14.3x forward estimates, up from roughly 10 to 13x in June after a ~62% three-month rally, though still below its 5-year average near 25x. Consensus calls for fiscal 2027 EPS of ~$14.66 on ~$77.4 billion of revenue, and trailing free cash flow of ~$11.2 billion covers the dividend (about a 51% payout ratio) and buybacks. The next report, for the quarter ending November 30, is scheduled for December 17, 2026.

FCN. FCN closed near $145.85 on October 16, 2026, within a 52-week range of roughly $129 to $189, down about 14% year to date. Its trailing P/E near 17.6x falls to about 13.4x on forward estimates, a discount that reflects margin worries and two straight EPS misses even as revenue keeps growing. Q3 2026 results are due October 29, with consensus near $2.74 per share on about $1.01 billion of revenue.

Headline figures (approximate, October 2026): ACN shows revenue (fy2026, ended aug 31 2026) ~$74.2 billion (+~6.5% YoY), q4 fy2026 revenue ~$18.7 billion (+~6.2% YoY), q4 fy2026 eps ~$3.29 (vs ~$3.18 consensus), net income (fy2026) ~$8.4 billion (~11.3% net margin); FCN shows revenue (ttm) ~$3.92B (Q2 2026 up ~5.3% YoY), revenue (q2 2026) ~$993M, net income (ttm) ~$253M (profit margin ~6.4%), eps (q2 2026 vs estimate) ~$1.99 vs ~$2.26.

ACN and FCN are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined ACN and FCN exposure against your real portfolio. It is not an investment adviser.